Neonatal HSV: Difference between revisions
(Added more background information re: prevalence, definitions) |
(added historical features, categories) |
||
Line 11: | Line 11: | ||
===Risk Factors in Neonatal Fever=== | ===Risk Factors in Neonatal Fever=== | ||
{{Pediatric fever acyclovir indications}} | {{Pediatric fever acyclovir indications}} | ||
===Classification=== | |||
*Whitney-Kimberlin disease categories | |||
**Disseminated (liver, lung, adrenal glands, skin, eye, brain) - 25% | |||
***2/3 have CNS involvement | |||
**CNS - 30% | |||
**SEM (skin, eye, mouth) - 45% | |||
***Conjunctival disease or minor skin lesions may be only manifestation | |||
****May go on to CNS, disseminated disease - workup and treat the same | |||
===Historical features=== | |||
*Not sensitive (maternal history of HSV), nor specific (maternal fever, vaginal delivery, preterm birth) (1) | |||
**80% of mothers have no history of genital lesions (3) | |||
*Vesicular lesions most specific, present in <1/2 (1) | |||
**Note: absence of vesicular rash does not rule out | |||
*'''May be well appearing''' - maintain high clinical suspicion | |||
*Ask about: | |||
**Temperature instability (fever, hypothermia) | |||
**Irritability | |||
**Lethargy | |||
**Seizures | |||
**Respiratory distress | |||
==Clinical Features== | ==Clinical Features== |
Revision as of 21:08, 2 July 2016
Background
- Causative agent: HSV-1 or HSV-2
- Definition – “infection acquired peri-natally or postnatally without clinical manifestations at birth or in the first 24 hours of life but with subsequent clinical manifestations in the neonatal period (age less than 29 days)” (1)
- ED prevalence:
- 0.2% all neonates
- 0.3% febrile neonates
- 0.5% neonates undergoing LP
- Prevalence similar to meningitis (0.4%) in neonates presenting for SBI (2)
- Risk associated with age <3 weeks, primary maternal HSV infection at delivery
Risk Factors in Neonatal Fever
^Acyclovir if:
Classification
- Whitney-Kimberlin disease categories
- Disseminated (liver, lung, adrenal glands, skin, eye, brain) - 25%
- 2/3 have CNS involvement
- CNS - 30%
- SEM (skin, eye, mouth) - 45%
- Conjunctival disease or minor skin lesions may be only manifestation
- May go on to CNS, disseminated disease - workup and treat the same
- Conjunctival disease or minor skin lesions may be only manifestation
- Disseminated (liver, lung, adrenal glands, skin, eye, brain) - 25%
Historical features
- Not sensitive (maternal history of HSV), nor specific (maternal fever, vaginal delivery, preterm birth) (1)
- 80% of mothers have no history of genital lesions (3)
- Vesicular lesions most specific, present in <1/2 (1)
- Note: absence of vesicular rash does not rule out
- May be well appearing - maintain high clinical suspicion
- Ask about:
- Temperature instability (fever, hypothermia)
- Irritability
- Lethargy
- Seizures
- Respiratory distress
Clinical Features
Differential Diagnosis
Diagnosis
Management
- Acyclovir 20 mg/kg IV every 8 hours (duration depends on classification)
- If ocular involvement:
- 1% trifluridine, 0.1% iododeoxyuridine, or 3% vidarabine
- Optho consult
- As for any febrile neonate SBI evaluation:
- Ampicillin + gentamycin
- May substitute gentamycin with cefotaxime/ceftazidime
- Ampicillin + gentamycin